LBX Pharmacy Chain Joint Stock Company (603883.SS)
CNY 20.15
(9.99%)
CNY 20.15
(9.99%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | 7.88 Billion CNY | 159.03% |
| 2022 | 3.04 Billion CNY | -34.04% |
| 2021 | 4.61 Billion CNY | 6950.02% |
| 2020 | -67.39 Million CNY | -114.56% |
| 2019 | 462.81 Million CNY | -21.41% |
| 2018 | 588.87 Million CNY | 310.19% |
| 2017 | -280.16 Million CNY | -163.99% |
| 2016 | 437.82 Million CNY | 164.47% |
| 2015 | -679.09 Million CNY | -465.48% |
| 2014 | -120.09 Million CNY | -57.89% |
| 2013 | -76.06 Million CNY | 55.62% |
| 2012 | -171.37 Million CNY | -5.17% |
| 2011 | -162.94 Million CNY | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q3 | 829.99 Million CNY | -62.59% |
| 2024 Q2 | 7.68 Billion CNY | 0.96% |
| 2024 Q1 | 7.6 Billion CNY | -3.55% |
| 2023 Q4 | 7.88 Billion CNY | 108.52% |
| 2023 Q1 | 2.96 Billion CNY | -2.61% |
| 2023 Q2 | 3.3 Billion CNY | 11.4% |
| 2023 Q3 | 3.78 Billion CNY | 14.49% |
| 2023 FY | 7.88 Billion CNY | 159.03% |
| 2022 Q4 | 3.04 Billion CNY | -18.11% |
| 2022 Q3 | 3.71 Billion CNY | 5.38% |
| 2022 Q2 | 3.52 Billion CNY | 15.5% |
| 2022 Q1 | 3.05 Billion CNY | -33.83% |
| 2022 FY | 3.04 Billion CNY | -34.04% |
| 2021 Q2 | 3.17 Billion CNY | 4.21% |
| 2021 Q3 | 3.43 Billion CNY | 8.19% |
| 2021 Q4 | 4.61 Billion CNY | 34.22% |
| 2021 FY | 4.61 Billion CNY | 6950.02% |
| 2021 Q1 | 3.05 Billion CNY | 4626.36% |
| 2020 Q2 | 621.59 Million CNY | -24.6% |
| 2020 Q3 | 508.96 Million CNY | -18.12% |
| 2020 Q4 | -67.39 Million CNY | -113.24% |
| 2020 FY | -67.39 Million CNY | -114.56% |
| 2020 Q1 | 824.42 Million CNY | 78.13% |
| 2019 Q3 | -42.8 Million CNY | -108.27% |
| 2019 Q1 | 524.15 Million CNY | -10.99% |
| 2019 Q2 | 517.67 Million CNY | -1.24% |
| 2019 FY | 462.81 Million CNY | -21.41% |
| 2019 Q4 | 462.81 Million CNY | 1181.32% |
| 2018 Q1 | -190.83 Million CNY | 31.88% |
| 2018 Q4 | 588.87 Million CNY | 24.89% |
| 2018 Q3 | 471.5 Million CNY | 402.09% |
| 2018 Q2 | 93.9 Million CNY | 149.21% |
| 2018 FY | 588.87 Million CNY | 310.19% |
| 2017 Q4 | -280.16 Million CNY | -173.1% |
| 2017 Q1 | 422.58 Million CNY | -3.48% |
| 2017 Q2 | 422.68 Million CNY | 0.02% |
| 2017 Q3 | 383.27 Million CNY | -9.32% |
| 2017 FY | -280.16 Million CNY | -163.99% |
| 2016 Q2 | -314.72 Million CNY | 48.46% |
| 2016 Q4 | 437.82 Million CNY | 305.55% |
| 2016 Q3 | 107.95 Million CNY | 134.3% |
| 2016 Q1 | -610.61 Million CNY | 10.08% |
| 2016 FY | 437.82 Million CNY | 164.47% |
| 2015 Q4 | -679.09 Million CNY | 25.36% |
| 2015 FY | -679.09 Million CNY | -465.48% |
| 2015 Q1 | -137.31 Million CNY | -14.35% |
| 2015 Q2 | -1.13 Billion CNY | -727.86% |
| 2015 Q3 | -909.84 Million CNY | 19.97% |
| 2014 FY | -120.09 Million CNY | -57.89% |
| 2014 Q1 | 390.99 Million CNY | 0.0% |
| 2014 Q3 | -103.63 Million CNY | 0.0% |
| 2014 Q4 | -120.09 Million CNY | -15.88% |
| 2013 FY | -76.06 Million CNY | 55.62% |
| 2012 FY | -171.37 Million CNY | -5.17% |
| 2011 FY | -162.94 Million CNY | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| Shanghai No.1 Pharmacy Co., Ltd. | -73.11 Million CNY | 10886.978% |
| Jointown Pharmaceutical Group Co., Ltd | 21.81 Billion CNY | 63.851% |
| Yifeng Pharmacy Chain Co., Ltd. | 6.48 Billion CNY | -21.543% |
| Yunnan Jianzhijia Health-Chain Co., Ltd. | 2.83 Billion CNY | -177.914% |